Andy Ziolkowski is a Managing Director of Cultivian Sandbox and Co-Founder and Managing Partner of Cultivian Ventures. Andy has over 30 years of experience in venture capital investing and merchant banking across a broad range of industries. His investment track record includes DexCom, Biomimetic Pharmaceuticals, FutureHealth, Tessera, i-STAT and The Liposome Company. Prior to founding Cultivian Ventures, Andy was a Managing Director of SAE Ventures and Forest Street Capital, where he spent fourteen years as an investor and advisor to early stage healthcare and technology companies. Previously, he was a Director of Venture Capital at Credit Suisse First Boston Merchant Bank.
Andy began his venture capital career at Whitehead Associates, a family investment fund. He was also an electrical engineer and plasma physicist at the Grumman Aerospace Corporation and Princeton University Plasma Physics Laboratory.
Andy represents Cultivian on the board of directors of AquaSpy, Descartes Labs, EOSi, Harvest Automation, Novihum Technologies, Novogy (exited) and Sample6. Andy holds a Masters of Business Administration from The Wharton School of Business and Finance, and has a Bachelors of Science in Engineering from the University of Pennsylvania, where he was a Grumman Scholar.
Fouad Azzam, PhD, an experienced venture capital leader, joined LSP in 2007 and became a General Partner of the firm later that same year. His prime focus and responsibility within LSP is to invest in unlisted securities and manage the firm’s North American operations. Prior to joining LSP, Dr. Azzam was the Managing Director of Eastman Ventures where he built-up its Healthcare and Advanced Materials practice. As Managing Director, he was responsible for numerous early- and late-stage investments across the US and Europe. Prior to his role at Eastman Ventures, Dr. Azzam held senior leadership positions in innovation and corporate development at Eastman Chemical as well as operating and technology roles at Occidental Chemical and BFGoodrich. Dr. Azzam is currently a Director at BioClin Therapeutics, Cardiac Dimensions, Endotronix, Illuminoss Medical, and Simplify Medical.
AquaSpy, Environmental Operating Solutions, and Novogy
Boundless Learning, Brontes Technologies, Contently, GiveForward, and Integral Ad Science
Cobalt Technologies, and Seahorse Bioscience
Cobalt Technologies, FlowCardia, Pasteuria Bioscience, and Seahorse Bioscience